Rosuvastatin Terminated Phase 2 Trials for Coronary Artery Disease / Dyslipidemias Basic Science

IndicationsStatusPurposePhase
TerminatedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT01863225Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia